Interim Principal Financial Officer (2019-2020) · INSMED Inc (INSM)

John Goll

A named executive officer of INSMED in every fiscal year CompBrief holds from FY2017 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$1,013,377

Salary $345,050Stock awards $124,996

FY2019: $832,283

7th of 7 named executive officers at Insmed by FY2020 total.

7 named officers on file for INSMED, FY2020

John Goll’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • INSM’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how INSMED’s whole pay program stands against its peers

  • INSMED’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on INSM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 1, 2021 (DEF 14A).

Free

Get John Goll’s full pay file as a PDF — free

More than this page: up to 10 years of John’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

John Goll compensation by year

INSMED Summary Compensation Table · all 4 fiscal years held
In US dollars, as INSMED reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020
Salary$297,590$306,520$330,584$345,050
Bonus$100,000$0$0$0
Stock awards$0$68,748$124,976$124,996
Option awards$274,958$206,264$225,023$375,013
Non-equity incentive$161,500$171,100$140,500$151,000
Pension and deferred compensation$0$0$0$0
All other$8,100$11,000$11,200$17,318
Total$842,148$763,632$832,283$1,013,377

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: INSMED Inc DEF 14A filed April 1, 2021, accession 0001140361-21-011236, and prior-year filings. Open the filing on EDGAR.

How this page was built: the INSMED Inc filed document, accession 0001140361-21-011236. Every figure is read from that document and cited to the page and table it appears in. Filed April 1, 2021.

$842K
$764K
$832K
$1.0M
FY17
FY18
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU9,624$320,383—
Option28,260—$23.75
Option1,885—$13.67
Option1,527—$17.16
Option4,395—$30.46
Option17,350—$13.91

Per the Outstanding Equity Awards at Fiscal Year-End table in INSMED Inc's FY2020 proxy; value at the fiscal year-end close, as the company printed it.

INSMED’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
William LewisPresident and CEO$6,185,704
Martina FlammerChief Medical Officer$3,934,370
Roger AdsettChief Operating Officer$3,293,946
Christine PellizzariFormer Chief Legal Officer$3,232,896
Sara BonsteinChief Financial Officer$2,721,790
S. Nicole SchaefferChief People Strategy Officer$1,647,229
John Goll · this pageInterim Principal Financial Officer (2019-2020)$1,013,377

The full INSMED compensation record

free company brief

This page is one person within INSMED's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the INSMED proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are INSMED's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

John Goll's compensation dossier · One-time report. No refunds.